Live feed07:27:00·1dPRReleasevia QuantisnowCardiol Therapeutics Expands U.S. MAVERIC Phase III Trial Network to Address Growing Interest in the Pivotal ProgramByQuantisnow·Wall Street's wire, on your screen.CRDL· Cardiol Therapeutics Inc.Health Care
